New Delhi | August 20, 2014 18:38 (IST)
Glenmark Pharmaceuticals SA, a wholly-owned unit of Glenmark, announces the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a statement.
Hyderabad | August 20, 2014 15:16 (IST)
The Indian drug major said in a filing with US Securities and Exchange Commission (SEC) that the issue is related to compliance with requirements of special packaging for child resistant blister packs for six products sold by the company in the United States from 2002 through 2011.
New Delhi | August 20, 2014 14:57 (IST)
The approval has been granted for Acyclovir tablets in strengths of 400 mg and 800 mg, Zydus Cadila said.
August 20, 2014 12:39 (IST)
Nearly 5 million equity shares of FDC changed hands in multiple block deals on BSE, Thomson Reuters data shows.
August 20, 2014 10:31 (IST)
A filing with the US Securities and Exchange Commission on Monday shows market share gains in key drugs in the US market, analysts say.
August 19, 2014 22:48 (IST)
With many drugs going off patent in the US, Indian pharma companies would continue to experience strong growth in American market, credit rating agency Icra has said.
August 18, 2014 23:02 (IST)
The government has extended the deadline to affix barcodes on mono cartons (ointments, eye/ear drops) by pharmaceutical companies to April 2015.
Hyderabad | August 15, 2014 10:55 (IST)
According to a notification by the USFDA, the recall of the 3,40,553 units of 500 mg and 1,13,677 units of 250 mg bottles is voluntarily initiated by the company through a letter to the regulator in June under Class-II classification.
August 13, 2014 18:33 (IST)
India's top 20 pharmaceutical companies would increase capital expenditure by 40 per cent to more than Rs 50,000 crore by fiscal year 2018, credit rating agency Crisil said on Wednesday.
August 13, 2014 16:22 (IST)
Drug firm Merck today reported a 25.83 per cent rise in its standalone net profit to Rs 20.99 crore for the second quarter ended June 30, 2014, mainly on robust sales.
San Francisco | August 12, 2014 16:39 (IST)
Apple Inc. has been discussing how its "HealthKit" service will work with health providers at Mount Sinai, the Cleveland Clinic and Johns Hopkins as well as with all scripts, a competitor to electronic health records provider Epic Systems, people familiar with the discussions said.
August 10, 2014 14:43 (IST)
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
August 05, 2014 08:23 (IST)
The British company's business has suffered since January after the inhaled medicine Advair was dropped from various formulary lists - including that of Express Scripts - while it fights growing price competition from rival products.
August 03, 2014 20:24 (IST)
Drug makers from India, the biggest source of medicines to the US, may soon have to cough up 12-15 per cent more in annual facility fees as the Food and Drug Administration (FDA) has announced new rates.
August 03, 2014 13:22 (IST)
The Bangalore-based firm is at present in 18 cities, including Chennai, Delhi and NCR, Mumbai, Pune, Hyderabad and Kolkata. It is looking to hire 5,000 people during the period.
Mumbai | August 01, 2014 19:28 (IST)
The lockout at the Thane plant, which employs 212 people, would have no impact on the group's supply of medicines, a Pfizer Ltd spokesman said in a statement emailed to Reuters.
July 30, 2014 21:18 (IST)
Mumbai-based Sun Pharmaceutical Industries will seek shareholders approval for its $4-billion acquisition of Ranbaxy Laboratories in a court-convened meeting on August 22.
July 30, 2014 11:31 (IST)
Dr Reddy's may report operating profit of Rs 742 crore ($123.3 million) as per SmartEstimates, versus the consensus mean of Rs 770 crore.
July 28, 2014 17:39 (IST)
Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the exercise based on "an inequitable formula" has done collateral damage to the ndigenous industry.
Mumbai | July 24, 2014 14:05 (IST)
Ipca, a mid-sized generic drugs and ingredients maker, said the FDA issued a so-called "Form 483", a letter in which the agency typically outlines violations of its guidelines observed during inspections of manufacturing plants. Ipca did not give details about the contents of the Form 483 that it had received.